Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

SangStat Medical reports encouraging phase III results with Thymoglobulin

July 29, 1997

DynaGen expands ImmuDyn development

July 24, 1997

Mycophenolic acid derivatives with immunosuppressive activity claimed

July 17, 1997

Intranasal flu vaccine effective and safe in children

July 16, 1997

Vical and Pasteur Merieux Connaught initiate phase I malaria trial

July 14, 1997

Virus Research Institute's rotavirus vaccine enters phase II

July 11, 1997

Lepetit discovers IL-1RI inhibitors from microbial samples

July 10, 1997

FDA grants manufacturing approval for bulk ciclosporin

July 8, 1997

Preliminary results reported for Cortecs' Flustat

July 7, 1997

Natural immunosuppressive agent disclosed by Kyowa Hakko

July 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...